401 related articles for article (PubMed ID: 21949739)
41. Signaling pathways perturbing muscle mass.
Glass DJ
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):225-9. PubMed ID: 20397318
[TBL] [Abstract][Full Text] [Related]
42. Developmental regulation of the activation of signaling components leading to translation initiation in skeletal muscle of neonatal pigs.
Suryawan A; Escobar J; Frank JW; Nguyen HV; Davis TA
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E849-59. PubMed ID: 16757550
[TBL] [Abstract][Full Text] [Related]
43. The Effect of Estradiol Administration on Muscle Mass Loss and Cachexia Progression in Female
Counts BR; Fix DK; Hetzler KL; Carson JA
Front Endocrinol (Lausanne); 2019; 10():720. PubMed ID: 31736871
[TBL] [Abstract][Full Text] [Related]
44. The Extract of
Han YH; Mun JG; Jeon HD; Yoon DH; Choi BM; Kee JY; Hong SH
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33086629
[TBL] [Abstract][Full Text] [Related]
45. Cachectic skeletal muscle response to a novel bout of low-frequency stimulation.
Puppa MJ; Murphy EA; Fayad R; Hand GA; Carson JA
J Appl Physiol (1985); 2014 Apr; 116(8):1078-87. PubMed ID: 24610533
[TBL] [Abstract][Full Text] [Related]
46. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I.
Brink M; Price SR; Chrast J; Bailey JL; Anwar A; Mitch WE; Delafontaine P
Endocrinology; 2001 Apr; 142(4):1489-96. PubMed ID: 11250929
[TBL] [Abstract][Full Text] [Related]
47. Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.
Narsale AA; Puppa MJ; Hardee JP; VanderVeen BN; Enos RT; Murphy EA; Carson JA
Oncotarget; 2016 Sep; 7(37):59482-59502. PubMed ID: 27449092
[TBL] [Abstract][Full Text] [Related]
48. Alcohol-induced IGF-I resistance is ameliorated in mice deficient for mitochondrial branched-chain aminotransferase.
Lang CH; Lynch CJ; Vary TC
J Nutr; 2010 May; 140(5):932-8. PubMed ID: 20237068
[TBL] [Abstract][Full Text] [Related]
49. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
Guo D; Wang C; Wang Q; Qiao Z; Tang H
Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
[TBL] [Abstract][Full Text] [Related]
50. Repeated eccentric contractions positively regulate muscle oxidative metabolism and protein synthesis during cancer cachexia in mice.
Hardee JP; Fix DK; Koh HJ; Wang X; Goldsmith EC; Carson JA
J Appl Physiol (1985); 2020 Jun; 128(6):1666-1676. PubMed ID: 32407241
[TBL] [Abstract][Full Text] [Related]
51. Role of adenosine 5'-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling.
Deshmukh AS; Treebak JT; Long YC; Viollet B; Wojtaszewski JF; Zierath JR
Mol Endocrinol; 2008 May; 22(5):1105-12. PubMed ID: 18276828
[TBL] [Abstract][Full Text] [Related]
52. High CO
Korponay TC; Balnis J; Vincent CE; Singer DV; Chopra A; Adam AP; Ginnan R; Singer HA; Jaitovich A
Am J Respir Cell Mol Biol; 2020 Jan; 62(1):74-86. PubMed ID: 31264907
[TBL] [Abstract][Full Text] [Related]
53. Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice.
Tsubouchi H; Yanagi S; Miura A; Matsumoto N; Kangawa K; Nakazato M
Eur J Pharmacol; 2014 Nov; 743():1-10. PubMed ID: 25257464
[TBL] [Abstract][Full Text] [Related]
54. Aerobic exercise, but not metformin, prevents reduction of muscular performance by AMPk activation in mice on doxorubicin chemotherapy.
de Lima EA; de Sousa LGO; de S Teixeira AA; Marshall AG; Zanchi NE; Neto JCR
J Cell Physiol; 2018 Dec; 233(12):9652-9662. PubMed ID: 29953589
[TBL] [Abstract][Full Text] [Related]
55. Role of interleukin-6 in cachexia: therapeutic implications.
Narsale AA; Carson JA
Curr Opin Support Palliat Care; 2014 Dec; 8(4):321-7. PubMed ID: 25319274
[TBL] [Abstract][Full Text] [Related]
56. Adenosine monophosphate-activated protein kinase is elevated in human cachectic muscle and prevents cancer-induced metabolic dysfunction in mice.
Raun SH; Ali MS; Han X; Henríquez-Olguín C; Pham TCP; Meneses-Valdés R; Knudsen JR; Willemsen ACH; Larsen S; Jensen TE; Langen R; Sylow L
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1631-1647. PubMed ID: 37194385
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia.
Bohnert KR; Gallot YS; Sato S; Xiong G; Hindi SM; Kumar A
FASEB J; 2016 Sep; 30(9):3053-68. PubMed ID: 27206451
[TBL] [Abstract][Full Text] [Related]
58. Sex differences in skeletal muscle alterations in a model of colorectal cancer.
Greenman AC; Albrecht DM; Halberg RB; Diffee GM
Physiol Rep; 2020 Mar; 8(5):e14391. PubMed ID: 32170841
[TBL] [Abstract][Full Text] [Related]
59. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice.
Jung TW; Lee SH; Kim HC; Bang JS; Abd El-Aty AM; Hacımüftüoğlu A; Shin YK; Jeong JH
Exp Mol Med; 2018 Sep; 50(9):1-11. PubMed ID: 30213948
[TBL] [Abstract][Full Text] [Related]
60. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
